1st Department of Obstetrics and Gynaecology, Ludwig-Maximilians-University Munich, Maistrasse 11, 80337 Munich, Germany.
Arch Gynecol Obstet. 2010 Aug;282(2):185-91. doi: 10.1007/s00404-009-1310-y. Epub 2009 Dec 11.
Inhibins and activins are important regulators of the female reproductive system. Recently, two novel inhibin subunits, named betaC and betaE, have been identified and shown to be expressed in several human tissues. However, only limited data on the expression of these novel inhibin subunits in normal human endometrial tissue and endometrial adenocarcinoma cell lines exist.
Samples of proliferative and secretory human endometrium were obtained from five premenopausal, non-pregnant patients undergoing gynecological surgery for benign diseases. Normal endometrial tissue and Ishikawa endometrial adenocarcinoma cell lines were analyzed by immunohistochemistry, immunofluorescence and RT-PCR.
Expression of the inhibin betaC and betaE subunits could be demonstrated at the protein level by means of immunohistochemical evaluation and at the transcriptional level by establishing a betaC- and betaE-specific RT-PCR analysis in normal human endometrial tissue and the parental Ishikawa cell line. Interestingly, in a highly de-differentiated subclone of the Ishikawa cell line lacking estrogen receptor expression, the expression of the inhibin-betaC subunit appeared strongly reduced.
Here, we show for the first time that the novel inhibin/activin-betaC and -betaE subunits are expressed in normal human endometrium and the estrogen receptor positive human endometrial carcinoma cell line Ishikawa using RT-PCR and immunohistochemical detection methods. Interestingly, the Ishikawa minus cell line (lacking estrogen receptor expression) demonstrated no to minimal expression of the betaC subunit as observed with immunofluorescence and RT-PCR, suggesting a possible hormone- dependency of this subunit in human endometrial cancer cells. Moreover, because the Ishikawa cell line minus is thought to be a more malignant endometrial cell line than its estrogen receptor positive counterpart, inhibin-betaC subunit might be substantially involved in the pathogenesis and malignant transformation in human endometrium.
抑制素和激活素是女性生殖系统的重要调节因子。最近,发现了两种新型抑制素亚基,分别命名为βC 和 βE,并证实它们在几种人体组织中表达。然而,关于这些新型抑制素亚基在正常人类子宫内膜组织和子宫内膜腺癌细胞系中的表达,仅有有限的数据。
从五名因良性疾病接受妇科手术的绝经前非妊娠患者中获取增殖期和分泌期的人子宫内膜样本。采用免疫组织化学、免疫荧光和 RT-PCR 分析正常子宫内膜组织和 Ishikawa 子宫内膜腺癌细胞系。
通过免疫组织化学评估和建立抑制素βC 和 βE 亚基特异性 RT-PCR 分析,在正常人类子宫内膜组织和 Ishikawa 母细胞系中,均可在蛋白水平和转录水平上证明抑制素βC 和 βE 亚基的表达。有趣的是,在 Ishikawa 细胞系的一个高度去分化亚克隆中,缺乏雌激素受体表达,抑制素-βC 亚基的表达似乎明显减少。
在这里,我们首次使用 RT-PCR 和免疫组织化学检测方法表明,新型抑制素/激活素-βC 和 -βE 亚基在正常人类子宫内膜和雌激素受体阳性的人类子宫内膜癌细胞系 Ishikawa 中表达。有趣的是,Ishikawa 缺失细胞系(缺乏雌激素受体表达)表现出免疫荧光和 RT-PCR 检测到的βC 亚基无或极少表达,表明该亚基在人类子宫内膜癌细胞中可能存在激素依赖性。此外,由于 Ishikawa 缺失细胞系被认为比其雌激素受体阳性的对应物更具恶性,抑制素-βC 亚基可能在人类子宫内膜的发病机制和恶性转化中起重要作用。